C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 261/14 (2006.01) A61K 31/381 (2006.01) A61K 31/415 (2006.01) A61K 31/42 (2006.01) A61K 31/426 (2006.01) A61K 31/4439 (2006.01) C07D 231/40 (2006.01) C07D 277/48 (2006.01) C07D 333/36 (2006.01)
Patent
CA 2315720
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.
L'invention a trait à l'utilisation d'un groupe d'aryle urées pour traiter des maladies, autres que le cancer, induites par des cytokines, et des maladies, autres que le cancer, induites par des enzymes protéolytiques; et à des compositions utiles pour ce type de thérapie.
Dumas Jacques
Hatoum-Mokdad Holia
Johnson Jeffrey
Khire Uday
Lee Wendy
Bayer Healthcare Llc
Corporation Bayer
Johnson Ernest Peter
LandOfFree
Inhibition of p38 kinase activity using substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of p38 kinase activity using substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of p38 kinase activity using substituted... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1708745